International Journal of Infection

Published by: Kowsar

Comparison of the Success Rate of Quadruple and Triple Antibiotic Therapy in Eradicating Helicobacter pylori Infection in Southwest of Iran: A Randomized Clinical Trial

Leila Manzouri 1 , Farzaneh Zarei 2 , Narjes Niazi 2 and Moslem Sedaghattalab 2 , *
Authors Information
1 Social Determinants of Health Research Center, Yasuj University of Medical Sciences, Yasuj, Iran
2 Department of internal medicine, Yasuj University of Medical Sciences, Yasuj, IR Iran
Article information
  • International Journal of Infection: July 2017, 4 (3); e15610
  • Published Online: June 21, 2017
  • Article Type: Research Article
  • Received: December 3, 2016
  • Revised: December 27, 2016
  • Accepted: December 28, 2016
  • DOI: 10.5812/iji.15610

To Cite: Manzouri L, Zarei F, Niazi N, Sedaghattalab M. Comparison of the Success Rate of Quadruple and Triple Antibiotic Therapy in Eradicating Helicobacter pylori Infection in Southwest of Iran: A Randomized Clinical Trial, Int J Infect. 2017 ; 4(3):e15610. doi: 10.5812/iji.15610.

Abstract
Copyright © 2017, International Journal of Infection. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Methods
3. Results
4. Discussion
Acknowledgements
Footnotes
References
  • 1. Song M, Ang TL. Second and third line treatment options for <italic>Helicobacter Pylori</italic> eradication. World J Gastroenterol. 2014; 20(6): 1517-28[DOI][PubMed]
  • 2. Picoli SU, Mazzoleni LE, Fernandez H, De Bona LR, Neuhauss E, Longo L, et al. Resistance to amoxicillin, clarithromycin and ciprofloxacin of <italic>Helicobacter Pylori</italic> isolated from Southern Brazil patients. Rev Inst Med Trop Sao Paulo. 2014; 56(3): 197-200[PubMed]
  • 3. Papastergiou V, Georgopoulos SD, Karatapanis S. Treatment of <italic>Helicobacter Pylori</italic> infection: meeting the challenge of antimicrobial resistance. World J Gastroenterol. 2014; 20(29): 9898-911[DOI][PubMed]
  • 4. John DV. Peptic ulcer disease and related disorders. Harrison's Principles of Internal Medicine. 2012; : 2442
  • 5. Huang TC, Lee CL. Diagnosis, treatment, and outcome in patients with bleeding peptic ulcers and <italic>Helicobacter Pylori</italic> infections. Biomed Res Int. 2014; 2014: 658108[DOI][PubMed]
  • 6. Rollan A, Arab JP, Camargo MC, Candia R, Harris P, Ferreccio C, et al. Management of <italic>Helicobacter Pylori</italic> infection in Latin America: a Delphi technique-based consensus. World J Gastroenterol. 2014; 20(31): 10969-83[DOI][PubMed]
  • 7. Fakheri H, Bari Z, Aarabi M, Malekzadeh R. <italic>Helicobacter Pylori</italic> eradication in West Asia: a review. World J Gastroenterol. 2014; 20(30): 10355-67[DOI][PubMed]
  • 8. Keshavarz AA. Omeprazole-based triple therapy with low-versus high-dose of clarithromycin plus amoxicillin forH pylorieradication in Iranian population. World J Gastroentero. 2007; 13(6): 930[DOI]
  • 9. Vafaeimanesh J, Jalalzadeh M, Nazarian M. Expression comparison of azithromycin and clarithromycin in triple therapy regimens for eradication of <italic>Helicobacter Pylori</italic> in hemodialysis patients. Saudi J Kidney Dis Transpl. 2014; 25(1): 53-7
  • 10. Venerito M, Krieger T, Ecker T, Leandro G, Malfertheiner P. Meta-analysis of bismuth quadruple therapy versus clarithromycin triple therapy for empiric primary treatment of <italic>Helicobacter Pylori</italic> infection. Digestion. 2013; 88(1): 33-45[DOI][PubMed]
  • 11. Masoodi M, Panahian M, Rezadoost A, Heidari A. Eradication Rate of <italic>Helicobacter Pylori</italic> using a Two-week Quadruple Therapy: A Report from Southern Iran. Middle East J Dig Dis. 2013; 5(2): 81-5[PubMed]
  • 12. Hosseini SM, Sharifipoor F, Nazemian F, Ghanei H, Zivarifar HR, Fakharian T. <italic>Helicobacter Pylori</italic> eradication in renal recipient: triple or quadruple therapy? Acta Med Iran. 2014; 52(4): 271-4[PubMed]
  • 13. Ghadir MR, Shafaghi A, Iranikhah A, Pakdin A, Joukar F, Mansour-Ghanaei F. Furazolidone, amoxicillin and omeprazole with or without bismuth for eradication of <italic>Helicobacter Pylori</italic> in peptic ulcer disease. Turk J Gastroenterol. 2011; 22(1): 1-5[PubMed]
  • 14. Khoshnood A, Hakimi P, Salman-Roghani H, Reza Mirjalili M. Replacement of clarithromycin with azithromycin in triple therapy regimens for the eradication of <italic>Helicobacter Pylori</italic>: A randomized clinical trial. J Med Life. 2014; 7(2): 254-9[PubMed]
  • 15. Malfertheiner P, Megraud F, O'Morain CA, Atherton J, Axon AT, Bazzoli F, et al. Management of <italic>Helicobacter Pylori</italic> infection--the Maastricht IV/ Florence Consensus Report. Gut. 2012; 61(5): 646-64[DOI][PubMed]
  • 16. Majlesi A, Khorasani MS, Aslani MM, Alikhani MY. Antibiotic susceptibility of <italic>Helicobacter Pylori</italic> clinical isolates in Hamadan, West of Iran. Inter J Enteric Pathogens. 2013; 1(1): 8-11
  • 17. Milani M, Ghotaslou R, Akhi MT, Nahaei MR, Hasani A, Somi MH, et al. The status of antimicrobial resistance of <italic>Helicobacter Pylori</italic> in Eastern Azerbaijan, Iran: comparative study according to demographics. J Infect Chemother. 2012; 18(6): 848-52[DOI][PubMed]
  • 18. Mohammadi M, Doroud D, Mohajerani N, Massarrat S. <italic>Helicobacter Pylori</italic> antibiotic resistance in Iran. World J Gastroenterol. 2005; 11(38): 6009-13[PubMed]
  • 19. Shokrzadeh L, Jafari F, Dabiri H, Baghaei K, Zojaji H, Alizadeh AH, et al. Antibiotic susceptibility profile of <italic>Helicobacter Pylori</italic> isolated from the dyspepsia patients in Tehran, Iran. Saudi J Gastroenterol. 2011; 17(4): 261-4[DOI][PubMed]
  • 20. Zendedel A, Moradimoghadam F, Almasi V, Zivarifar H. Antibiotic resistance of <italic>Helicobacter Pylori</italic> in Mashhad, Iran. J Pak Med Assoc. 2013; 63(3): 336-9[PubMed]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:

Author(s):

Article(s):

Create Citiation Alert
via Google Reader

Readers' Comments